MATTHEW ROBERTS: Open Payments
NPI 1598423543 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 54 payments from 16 companies in 2025. Trend: 2023 $936 · 2024 $1,485 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $340 |
| Lilly USA, LLC | 13 | $256 |
| Axsome Therapeutics, Inc. | 2 | $190 |
| Amgen Inc. | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $108 |
| Corcept Therapeutics | 3 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| PFIZER INC. | 3 | $62 |
Products named: VRAYLAR, Auvelity, JARDIANCE, REPATHA, QULIPTA, LEQVIO, Korlym, CAPLYTA.
Industry payments across MO — which companies pay providers there.
